Our experienced team of clinical safety experts will create a customized concept for allover safety monitoring for your IITs (Investigator Initiated Trial), non-interventional study (NIS) or Post Authorization Safety Study (PASS) in many indications such as diabetes, hematology, oncology, immunotherapy, pneumology and cardiology.
GWT - Your partner for optimal safety monitoring in clinical trials since more than 25 years
Your benefits at a glance
- Reliable partner for recording and reporting SAEs and adverse events.
- Close cooperation with European network of trial sites and CROs.
- Efficient, transparent communication and early risk identification.
- Extensive know-how in safety monitoring of multinational, multicenter studies.
- Structured processes according to current regulatory requirements and guidelines.
Effective Clinical Safety with GWT experts
Petra Gerteis
Wera Kupetz
Pharmacovigilance according to ICH-GCP: GWT - Safety & Welfare for Patients in Clinical Trials
GWT: Your expert for pharmacovigilance in clinical trials.
Pharmacovigilance is of central importance in clinical trials, focusing on patient safety and well-being. Our team, together with our partners (CROs and the medical experts), ensures accurate recording and reporting of SAEs and adverse events, early risk identification and compliance with all regulations. With 25+ years of experience and the goal of highest safety for study participants, we support your study according to ICH-GCP guidelines.
Trust our expertise in patient safety, data integrity and individual solutions. Together for the success of your projects.